Akèy › Anplwayè › Transpire Bio Inc.
Transpire Bio Inc.: Salè H-1B ak pajon
Transpire Bio Inc. depoze 12 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 12. Medyèn salè yo ofri a: $127,500.
Èske Transpire Bio Inc. pajone visa H-1B?
Transpire Bio Inc. depoze 12 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou May 14, 2026. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.
Salè pa tit travay
| Tit travay | LCA | Salè medyan |
|---|---|---|
| Senior Scientist II | 2 | $150,000 |
| Investor Relations & Public Relations Specialist | 2 | $70,000 |
| Scientist II | 1 | $114,000 |
| Associate Scientist II (Formulations) | 1 | $76,000 |
| Director , Validation | 1 | $215,000 |
| Analytical Team Lead | 1 | $145,000 |
| Senior Director of Device Engineering | 1 | $271,648 |
| Associate Scientist I | 1 | $70,000 |
| Director, Head of Formulations, Solid Dose | 1 | $205,000 |
| Scientist I | 1 | $115,000 |
Aplikasyon pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2024 | 1 | $114,000 |
| FY2025 | 3 | $140,000 |
| FY2026 | 8 | $130,000 |
Nivo salè prevanlan
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Kote travay yo ye
Okipasyon
- Chemists5
- Medical Scientists, Except Epidemiologists2
- Public Relations Specialists2
- Chemical Engineers1
- Industrial Engineers1
- Materials Scientists1
Dènye aplikasyon yo
| Tit travay | Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|---|
| Associate Scientist I | $70,000 Nivo II | Weston, FL | May 14, 2026 | Oct 1, 2026 | Certifye |
| Senior Scientist II | $160,000 Nivo IV | Weston, FL | May 14, 2026 | Oct 1, 2026 | Certifye |
| Scientist I | $115,000 Nivo IV | Weston, FL | May 14, 2026 | Oct 1, 2026 | Certifye |
| Director, Head of Formulations, Solid Dose | $205,000 Nivo IV | Weston, FL | May 14, 2026 | Oct 1, 2026 | Certifye |
| Senior Director of Device Engineering | $271,648 Nivo IV | Weston, FL | May 14, 2026 | Oct 1, 2026 | Certifye |
| Investor Relations & Public Relations Specialist | $70,000 Nivo II | Weston, FL | May 14, 2026 | Jun 1, 2026 | Certifye |
| Investor Relations & Public Relations Specialist | $70,000 Nivo I | Weston, FL | May 14, 2026 | Jun 1, 2026 | Certifye |
| Analytical Team Lead | $145,000 Nivo III | Weston, FL | Sep 29, 2025 | Oct 6, 2025 | Certifye |
| Senior Scientist II | $140,000 Nivo III | Weston, FL | May 5, 2025 | Oct 1, 2025 | Certifye |
| Director , Validation | $215,000 Nivo III | Weston, FL | May 5, 2025 | Jun 2, 2025 | Certifye, apre retire |
| Associate Scientist II (Formulations) | $76,000 Nivo II | Miami, FL | Oct 30, 2024 | Dec 2, 2024 | Certifye |
| Scientist II | $114,000 Nivo III | Weston, FL | Aug 19, 2024 | Sep 3, 2024 | Certifye |
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).